These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 23345327)

  • 1. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules.
    Tallerico R; Todaro M; Di Franco S; Maccalli C; Garofalo C; Sottile R; Palmieri C; Tirinato L; Pangigadde PN; La Rocca R; Mandelboim O; Stassi G; Di Fabrizio E; Parmiani G; Moretta A; Dieli F; Kärre K; Carbone E
    J Immunol; 2013 Mar; 190(5):2381-90. PubMed ID: 23345327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.
    Hecht ML; Rosental B; Horlacher T; Hershkovitz O; De Paz JL; Noti C; Schauer S; Porgador A; Seeberger PH
    J Proteome Res; 2009 Feb; 8(2):712-20. PubMed ID: 19196184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cells recognize and kill human glioblastoma cells with stem cell-like properties.
    Castriconi R; Daga A; Dondero A; Zona G; Poliani PL; Melotti A; Griffero F; Marubbi D; Spaziante R; Bellora F; Moretta L; Moretta A; Corte G; Bottino C
    J Immunol; 2009 Mar; 182(6):3530-9. PubMed ID: 19265131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
    Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.
    Koch J; Steinle A; Watzl C; Mandelboim O
    Trends Immunol; 2013 Apr; 34(4):182-91. PubMed ID: 23414611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Natural Cytotoxicity Receptors in Health and Disease.
    Barrow AD; Martin CJ; Colonna M
    Front Immunol; 2019; 10():909. PubMed ID: 31134055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
    J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
    Morrison BJ; Steel JC; Morris JC
    BMC Cancer; 2018 Apr; 18(1):469. PubMed ID: 29699516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
    Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
    Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44).
    De Maria A; Fogli M; Costa P; Murdaca G; Puppo F; Mavilio D; Moretta A; Moretta L
    Eur J Immunol; 2003 Sep; 33(9):2410-8. PubMed ID: 12938217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30).
    Mavoungou E; Bouyou-Akotet MK; Kremsner PG
    Clin Exp Immunol; 2005 Feb; 139(2):287-96. PubMed ID: 15654827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.
    Verstrepen BE; Nieuwenhuis IG; Mooij P; Bogers WM; Boonstra A; Koopman G
    Clin Exp Immunol; 2016 Jul; 185(1):42-9. PubMed ID: 26850369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors.
    Le Maux Chansac B; Moretta A; Vergnon I; Opolon P; Lécluse Y; Grunenwald D; Kubin M; Soria JC; Chouaib S; Mami-Chouaib F
    J Immunol; 2005 Nov; 175(9):5790-8. PubMed ID: 16237071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling natural killer cell function: triggering and inhibitory human NK receptors.
    Moretta L; Moretta A
    EMBO J; 2004 Jan; 23(2):255-9. PubMed ID: 14685277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
    Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
    J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
    Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of CD24(+) ovarian cancer cells to anti-cancer drugs and natural killer cells.
    Koh J; Lee SB; Park H; Lee HJ; Cho NH; Kim J
    Biochem Biophys Res Commun; 2012 Oct; 427(2):373-8. PubMed ID: 22995296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.